Role of sodium glucose co-transporter 2 inhibitor in preventing age-associated diseases (IMAGE)
Caption
Researchers from Juntendo University, Japan examine the molecular mechanisms underlying the senolytic or senescent cell removal effects of the the sodium glucose co-transporter 2 inhibitor and its therapeutic potential in the treatment of aging-related pathologies.
Credit
Professor Tohru Minamino from Juntendo University, Japan
Usage Restrictions
You are free to share and adapt the Infographic material but attribution is required, with a link to the news source.
License
Original content